India Likely To Have COVID Vaccine For Children Above 2 Years By September-October: AIIMS Director

Hopefully, by September-October, well have vaccines from our nation which we can provide to kids: Dr Guleria




Maharashtra60,17,035 9,6041,23,866 1,04557,72,799 10,1381,20,370 511Kerala28,65,871 11,5461,00,680 37227,52,492 11,05612,699 118Karnataka28,26,754 3,3101,07,218 3,32826,84,997 6,52434,539 114Tamil Nadu24,55,332 5,75547,318 2,52723,75,963 8,13232,051 150Andhra Pradesh18,71,475 4,45847,790 1,89318,11,157 6,31312,528 38Uttar Pradesh17,05,220 2063,423 12916,79,416 32022,381 15West Bengal14,91,219 1,93322,231 7714,51,437 1,97517,551 35Delhi14,33,590 1151,680 8714,06,958 19824,952 4Chhattisgarh9,92,684 2936,889 4259,72,372 71013,423 8Rajasthan9,51,826 1311,873 1469,41,048 2778,905 Odisha8,93,508 2,91229,565 7728,60,142 3,6443,801 40Gujarat8,23,010 1234,116 3118,08,849 43110,045 3Madhya Pradesh7,89,611 501,110 1707,79,630 1988,871 22Haryana7,68,142 1401,927 637,56,864 1859,351 18Bihar7,20,924 2072,397 1617,08,951 3659,576 3Telangana6,18,837 1,06115,524 5065,99,695 1,5563,618 11Punjab5,94,279 3384,832 4425,73,491 76815,956 12Assam4,96,481 2,79329,804 1,2104,62,307 3,9774,370 26Jharkhand3,45,161 1331,184 403,38,870 1725,107 1Uttarakhand3,39,373 1282,627 1123,29,663 2317,083 9Jammu And Kashmir3,13,974 4986,157 3803,03,526 8714,291 7Himachal Pradesh2,01,363 1531,956 1671,95,942 3183,465 2Goa1,65,648 2222,667 601,59,954 2773,027 5Puducherry1,16,186 2612,970 1071,11,477 3631,739 5Manipur66,756 5855,668 3,50659,995 4,0831,093 8Tripura64,159 2913,726 10259,768 390665 3Chandigarh61,581 39241 660,533 45807 Meghalaya47,480 6024,665 24142,001 354814 7Arunachal Pradesh34,480 2662,523 4231,792 305165 3Nagaland24,759 1301,508 122,770 129481 2Ladakh19,920 17293 2119,425 38202 Sikkim19,811 1302,255 2717,257 156299 1Mizoram19,091 2324,448 714,554 23889 1Dadra And Nagar Haveli10,530 452 710,474 114 Lakshadweep9,632 31313 99,271 3948 1Andaman And Nicobar Islands7,441 169 307,245 31127 Show MoreShow Less.

HighlightsCovaxin information for children after completion of trials expected by SeptemberCovaxin is a native vaccine established by Bharat Biotech & & & ICMR Bharat Biotech conducting trials between the age of 2 to 18 years New Delhi: Noting that children usually have a moderate illness however there is a need to establish COVID-19 vaccines for them, AIIMS Delhi Director Dr Randeep Guleria has actually mentioned Bharat Biotech and other business are doing trials at an extremely fast lane and hoped that information will result in approvals so that there is a vaccine for kids in the country by September-October. In an interview with ANI, Dr Guleria specified that Covaxins info for children after completion of stage 2 or 3 trials is anticipated by September-October.
Covaxin is a native vaccine established by Bharat Biotech in cooperation with ICMR.
If we need to control this pandemic everyone needs to be inoculated, kids typically have the mild illness nevertheless we require to establish vaccines for kids due to the truth that. Bharat Biotech and other companies are doing trials at a very quick pace as parents have advance with their children for the trials, he mentioned.
Read: Vaccination Needs To Be Boosted Massively As The Contagious Delta Variant Of COVID-19 Continues To Spread, Says Epidemiologist Dr Eric Feigl-Ding
One is hopeful that trial will be ended up early and possibly with follow up of about two-three months, we will have details by September. Hopefully, by that time, approvals will exist so that by September-October, well have vaccines from our country which we can offer to children, he consisted of.
Dr Guleria specified Bharat Biotech is performing trials in between the age of 2 to 18 years and “this covers a broad spectrum”.
Asked About Zydus Cadila vaccine, he mentioned it is a DNA vaccine, a brand-new platform is being used and “it is something that we must pleased with”.
He included that it is a platform for which research study has really not been performed in past in the nation.
The info is still being collected and one is hoping that they will have the ability to submit the info to the DCGI for regulative approval. It will depend on business how rapidly it has the ability to collect the information and offer it to the regulative authority, he said.
Inquired About Pfizer CEO mentioning that the business remains in the “last stages” of getting approval for its COVID-19 vaccine in India, Dr Guleria said that the company has actually stayed in negotiations for some time and these would have possibly reached the final stage.
One is positive that it must take place due to the fact that the settlements with the company is going on for quite some time. I make particular now they are reaching a stage where last sort understanding will exist, he specified.
( Except for the headline, this story has in fact not been edited by NDTV personnel and is launched from a syndicated feed.).
18,04,04,605 Cases.
5,83,73,106 Active.
11,81,22,090 Recovered.
39,09,409 Deaths.
Coronavirus has actually contaminated 194 countries. The total confirmed cases worldwide are 18,04,04,605 and 39,09,409 have actually died; 5,83,73,106 are active cases and 11,81,22,090 have actually recuperated as on June 26, 2021 at 3:48 am.India.
3,01,83,143 48,698 Cases.
5,95,56517,303 Active.
2,91,93,085 64,818 Recovered.
3,94,493 1,183 Deaths.
In India, there are 3,01,83,143 validated cases consisting of 3,94,493 deaths. The number of active cases is 5,95,565 and 2,91,93,085 have recuperated as on June 26, 2021 at 2:30 am.State Details.